miglitol vs nifedipine

According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.

Side-by-side comparison of miglitol and nifedipine. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

minor Known Drug Interaction

No effect of miglitol was observed on the pharmacokinetics or pharmacodynamics of either warfarin or nifedipine.

Drug Class
miglitol Alpha-Glucosidase Inhibitor
nifedipine Calcium Channel Blocker
Type
miglitol Prescription
nifedipine Prescription
Summary
miglitol

Miglitol (Glyset) helps control blood sugar in adults with type 2 diabetes. It should be used with diet and exercise.

nifedipine

Nifedipine is a calcium channel blocker. It helps to relax blood vessels, which can lower blood pressure and reduce chest pain.

What It Treats
miglitol

Miglitol treats type 2 diabetes. It helps lower your blood sugar levels after meals. You should use it along with a healthy diet and regular exercise to manage your diabetes.

nifedipine

This medicine treats chest pain (angina) caused by tight blood vessels. It also treats high blood pressure. Lowering blood pressure reduces the risk of strokes and heart attacks.

How It Works
miglitol

Miglitol slows down the digestion of carbohydrates. This helps to prevent a large rise in blood sugar after you eat. It works in your gut to block certain enzymes.

nifedipine

Nifedipine blocks calcium from entering heart and blood vessel cells. This relaxes and widens blood vessels. As a result, the heart doesn't have to work as hard, and blood pressure goes down.

Common Side Effects
miglitol
  • Gas
  • Diarrhea
  • Abdominal pain
nifedipine
  • Swelling, especially in the legs or ankles
  • Headache
  • Fatigue
  • Dizziness
  • Constipation
FAERS Reports
miglitol
  • Hypoglycaemia 67
  • Hepatic Function Abnormal 46
  • Decreased Appetite 39
  • Diarrhoea 37
  • Renal Impairment 37
nifedipine
  • Dyspnoea 2,429
  • Fatigue 2,304
  • Diarrhoea 2,264
  • Nausea 2,220
  • Headache 1,997
Serious Warnings
miglitol

No specific warnings noted.

nifedipine

In rare cases, nifedipine can cause serious gastrointestinal problems, including obstruction. If you experience severe abdominal pain, vomiting, or inability to pass stool, seek immediate medical attention.

Pregnancy
miglitol

There is not enough information about the safety of miglitol during pregnancy or breastfeeding. Talk to your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.

nifedipine

Tell your doctor if you are pregnant or plan to become pregnant. It is not known if nifedipine will harm your unborn baby. Talk to your doctor about the risks and benefits of taking this medicine while pregnant or breastfeeding.

Also Compare, Nearby Drugs

How to Read This miglitol vs nifedipine Comparison

miglitol is classified in the Alpha-Glucosidase Inhibitor drug class, while nifedipine sits within the Calcium Channel Blocker class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, miglitol has 226 submissions while nifedipine has 11,214. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to miglitol does not interfere with how nifedipine works or how much of it stays in your system.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for miglitol or nifedipine.

Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.